ENTEROVIRUS MYOCARDITIS

This adverse event was reported 19 times

ENTEROVIRUS MYOCARDITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 UBLITUXIMAB 1 0.0003
1 ATOVAQUONE 1 0.0001
2 OXYBUTYNIN CHLORIDE 1 0.0001
3 CHOLESTYRAMINE 1 0.0001
4 OCRELIZUMAB 5 0.0001
5 LOPERAMIDE HCL 1 0.0001
6 KETOCONAZOLE FOAM 1 0.0001
7 KETOCONAZOLE CREAM, 2% 1 0.0001
8 MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE 1 0.0001
9 KETOCONAZOLE 1 0.0001
See all drugs enriched for association with ENTEROVIRUS MYOCARDITIS